healthprotocol.wiki
Protocols
Evidence
Outcomes
Home
/
Evidence
david-kaufman_2025_cohort_tirzepatide-microdosing-long-covid-symptom-reduction
4 findings
Protocol
medication-diabetes-tirzepatide-microdosing
Outcome
cognition-brain-fog-severity-decrease-60-to-90-percent-self-reported
n
350
effect
75
attribution
40
Protocol
medication-diabetes-tirzepatide-microdosing
Outcome
immune-mast-cell-activation-syndrome-symptom-severity-decrease-60-to-90-percent-self-reported
n
350
effect
75
attribution
40
Protocol
medication-diabetes-tirzepatide-microdosing
Outcome
pain-severity-decrease-60-to-90-percent-self-reported
n
350
effect
75
attribution
40
Protocol
medication-diabetes-tirzepatide-microdosing
Outcome
vitality-fatigue-severity-decrease-60-to-90-percent-self-reported
n
350
effect
75
attribution
40
